Celltrion’s COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation
Regdanvimab (CT-P59) receives conditional marketing authorisation from the Korean Ministry of Food and Drug Safety (MFDS); first anti-COVID-19 monoclonal antibody...






